Alex Zhavoronkov, Founder and CEO of Insilico Medicine, discusses the implications after an AI-discovered lung drug developed by his company showed promise in reversing biological signs of aging. (Source: Bloomberg)
Alex Zhavoronkov, Founder and CEO of Insilico Medicine, discusses the implications after an AI-discovered lung drug developed by his company showed promise in reversing biological signs of aging. (Source: Bloomberg)
<iframe src="https://statesidedaily.com/embed/cluster/3e57523377f9fbb35a22ac6fc681f8b36afd245c" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Insilico's Lung Drug Reverses Aging Markers in Study"></iframe>